Risk Factors and Adverse Outcomes of Severe Hypoglycemia in Type 2 Diabetes Mellitus

다국어 초록 (Multilingual Abstract)

Hypoglycemia has been considered as a major barrier to achieving the proper glycemic target in type 2 diabetes mellitus patients.
In particular, severe hypoglycemia (SH), which is defined as a hypoglycemic episode requiring the assistance of another person to raise the patient’s glucose level, is a serious complication of diabetes because of its possible fatal outcomes. Recently, the recommendations for diabetes care have emphasized a patient-centered approach, considering the individualized patient factors including hypoglycemia. Many studies have been performed which analyzed the risk factors and clinical outcomes for SH. From the studies, researchers recommend that targeting a less stringent glycosylated hemoglobin level and selecting a safer class of drugs for hypoglycemia are appropriate for patients with a high risk of SH. Also, careful clinical attention to prevent hypoglycemia, including intensive education, is necessary to minimize the risk of SH and SH-related fatal outcomes.

참고문헌 (Reference)

1 Sommerfield AJ, "Vessel wall stiffness in type 1 diabetes and the central hemodynamic effects of acute hypoglycemia" 293 : E1274-E1279, 2007

2 Wright RJ, "Vascular disease and diabetes: is hypoglycaemia an aggravating factor?" 24 : 353-363, 2008

3 Korean Diabetes Association, "Treatment guideline for diabetes" Gold Planning and Development 2015

4 Miller ME, "The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study" 340 : b5444-, 2010

5 Bonds DE, "The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes:retrospective epidemiological analysis of the ACCORD study" 340 : b4909-, 2010

6 Kelly TN, "Systematic review: glucose control and cardiovascular disease in type 2 diabetes" 151 : 394-403, 2009

7 McAulay V, "Symptoms of hypoglycaemia in people with diabetes" 18 : 690-705, 2001

8 American Diabetes Association, "Standards of medical care in diabetes: 2016" 39 (39): S1-S106, 2016

9 Kong AP, "Severe hypoglycemia identifies vulnerable patients with type 2 diabetes at risk for premature death and all-site cancer: the Hong Kong diabetes registry" 37 : 1024-1031, 2014

10 Zoungas S, "Severe hypoglycemia and risks of vascular events and death" 363 : 1410-1418, 2010

11 Goto A, "Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis" 347 : f4533-, 2013

12 차선아, "Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes" 대한당뇨병학회 40 (40): 202-210, 2016

13 Gerich JE, "Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications" 27 : 136-142, 2010

14 UK Hypoglycaemia Study Group, "Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration" 50 : 1140-1147, 2007

15 Chow E, "Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk" 63 : 1738-1747, 2014

16 Quilliam BJ, "Risk factors for hypoglycemia-related hospitalization in patients with type 2 diabetes: a nested case-control study" 33 : 1781-1791, 2011

17 Cersosimo E, "Renal substrate metabolism and gluconeogenesis during hypoglycemia in humans" 49 : 1186-1193, 2000

18 MacMahon S, "Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies" 357 : 455-462, 2001

19 Cukierman-Yaffe T, "Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORDMIND)trial" 32 : 221-226, 2009

20 Puente EC, "Recurrent moderate hypoglycemia ameliorates brain damage and cognitive dysfunction induced by severe hypoglycemia" 59 : 1055-1062, 2010

21 Davis M, "Recovery of epinephrine response but not hypoglycemic symptom threshold after intensive therapy in type 1 diabetes" 97 : 535-542, 1994

22 Strachan MW, "Recovery of cognitive function and mood after severe hypoglycemia in adults with insulin-treated diabetes" 23 : 305-312, 2000

23 Yun JS, "Presence of macroalbuminuria predicts severe hypoglycemia in patients with type 2 diabetes: a 10-year follow-up study" 36 : 1283-1289, 2013

24 Punthakee Z, "Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes:post hoc epidemiologic analysis of the ACCORD trial" 35 : 787-793, 2012

25 Cryer PE, "Mechanisms of hypoglycemia-associated autonomic failure in diabetes" 369 : 362-372, 2013

26 Robinson RT, "Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia" 52 : 1469-1474, 2003

27 Inzucchi SE, "Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)" 35 : 1364-1379, 2012

28 Gerich JE, "Lilly lecture 1988. Glucose counterregulation and its impact on diabetes mellitus" 37 : 1608-1617, 1988

29 Widom B, "Intermittent hypoglycemia impairs glucose counterregulation" 41 : 1597-1602, 1992

30 McCoy RG, "Intensive treatment and severe hypoglycemia among adults with type 2 diabetes" 176 : 969-978, 2016

31 UK Prospective Diabetes Study Group, "Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)" 352 : 837-853, 1998

32 ADVANCE Collaborative Group, "Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes" 358 : 2560-2572, 2008

33 Weir MA, "Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: a population-based nested case-control study" 26 : 1888-1894, 2011

34 Whitmer RA, "Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus" 301 : 1565-1572, 2009

35 Fidler C, "Hypoglycemia: an overview of fear of hypoglycemia, quality-of-life, and impact on costs" 14 : 646-655, 2011

36 Cox DJ, "Hypoglycemia preceding fatal car collisions" 29 : 467-468, 2006

37 Miller CD, "Hypoglycemia in patients with type 2 diabetes mellitus" 161 : 1653-1659, 2001

38 Cox DJ, "Hypoglycemia anticipation, awareness and treatment training (HAATT) reduces occurrence of severe hypoglycemia among adults with type 1 diabetes mellitus" 11 : 212-218, 2004

39 Seaquist ER, "Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society" 36 : 1384-1395, 2013

40 Duning T, "Hypoglycemia aggravates critical illness-induced neurocognitive dysfunction" 33 : 639-644, 2010

41 Lin CH, "Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study" 273 : 102-110, 2013

42 Henderson JN, "Hypoglycaemia in insulin-treated type 2 diabetes: frequency, symptoms and impaired awareness" 20 : 1016-1021, 2003

43 Frier BM, "Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications" 10 : 711-722, 2014

44 Lindstrom T, "Hypoglycaemia and cardiac arrhythmias in patients with type 2 diabetes mellitus" 9 : 536-541, 1992

45 Signorovitch JE, "Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs" 15 : 335-341, 2013

46 Duckworth W, "Glucose control and vascular complications in veterans with type 2 diabetes" 360 : 129-139, 2009

47 Akram K, "Frequency and risk factors of severe hypoglycaemia in insulin-treated type 2 diabetes: a cross-sectional survey" 23 : 750-756, 2006

48 Yoon KH, "Epidemic obesity and type 2 diabetes in Asia" 368 : 1681-1688, 2006

49 Action to Control Cardiovascular Risk in Diabetes Study Group, "Effects of intensive glucose lowering in type 2 diabetes" 358 : 2545-2559, 2008

50 Koivikko ML, "Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes" 51 : 426-435, 2008

51 Ray KK, "Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials" 373 : 1765-1772, 2009

52 ORIGIN Trial Investigators, "Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial" 34 : 3137-3144, 2013

53 Davis TM, "Determinants of severe hypoglycemia complicating type 2diabetes: the Fremantle diabetes study" 95 : 2240-2247, 2010

54 Workgroup on Hypoglycemia, American Diabetes Association, "Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia" 28 : 1245-1249, 2005

55 Strachan MW, "Cognitive function, dementia and type 2 diabetes mellitus in the elderly" 7 : 108-114, 2011

56 de Galan BE, "Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE)trial" 52 : 2328-2336, 2009

57 Gill GV, "Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes: the ‘dead in bed’ syndrome revisited" 52 : 42-45, 2009

58 윤재승, "Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes" 대한내과학회 30 (30): 6-16, 2015

59 Goto A, "Association between severe hypoglycemia and cardiovascular disease risk in Japanese patients with type 2 diabetes" 5 : e002875-, 2016

60 Lu CL, "A population-based study of all-cause mortality and cardiovascular disease in association with prior history of hypoglycemia among patients with type 1 diabetes" 39 : 1571-1578, 2016